BCL2 and neoplasm: In recent years, multiple cocktail therapies have been developed to improve drug efficacy and reduce drug resistance, among them the combination of chemotherapeutics and siRNA is regarded as one of the promising schemes.23 The Bcl-2 protein family is closely related to the occurrence of tumor resistance to chemotherapeutics and is also involved in the mechanism of many apoptotic inducers.